---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-040374"
form_type: "8-K"
ticker: "NUWE"
cik: "0001506492"
company_name: "Nuwellis, Inc."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T03:29:11.081159+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nuwellis Q3 revenue $2.1M (+11% YoY); net loss narrows to $3.9M

## Summary
- Revenue $2.1M, up 11% from Q3 2021; gross margin 61% vs. 60.4%.
- Net loss $3.9M ($0.37 loss/share) vs. $5.3M ($0.75 loss/share) a year ago.
- SG&A expenses $4.3M vs. $4.6M; R&D expenses $0.9M vs. $1.7M.
- Cash $12.1M at Sep 30; closed $11M public offering on Oct 18, pro-forma cash ~$21.9M.
- Activated 3 sites for REVERSE-HF study; awarded U.S. patent for pediatric dialysis innovation.

## SEC filing metadata
- accession: 0001140361-22-040374
- form_type: 8-K
- ticker: NUWE
- cik: 0001506492
- company_name: Nuwellis, Inc.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506492/000114036122040374/0001140361-22-040374-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506492/000114036122040374/brhc10043820_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-040374
- JSON: https://secwatch.observer/filing/0001140361-22-040374.json
- Plain text: https://secwatch.observer/filing/0001140361-22-040374.txt

## Key facts
- Earnings Releases
  Nuwellis, Inc. reported the three and nine months ended September 30, 2022 results: revenue $2.1 million, net income $3.9 million, EPS $0.37 per basic and diluted common share.
  - Period: the three and nine months ended September 30, 2022
  - Revenue: $2.1 million
  - Net income: $3.9 million
  - EPS: $0.37 per basic and diluted common share
  - Result: reported results
  source text: the lives of people with fluid overload, today reported financial results for the third quarter ended September 30, 2022. Q3 Results and Recent Highlights: • Revenue of $2.1 million in the third quarter 2022, an 11% increase over the same year ago period • Gross margin of 61% was consistent with the same period last year • Activated three additional sites
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506492/000114036122040374/0001140361-22-040374-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.